U S Physical Therapy (USPH) risk factors, FY2025 10-K

U S Physical Therapy's FY2025 10-K, filed Feb 27, 2026, lists 37 risk factors in 2 groups. Against the prior year's 35: 2 new, 2 substantially reworded.

Risk factors listed
372 groups
New this year
2vs 35 last year
Dropped
0since the prior 10-K
Substantially reworded
2of those kept
Section length
7k wordsItem 1A

What the changes say

  • Medicare revenue grew to $213.5 million with an expected 1.75% rate increase for 2026 under the MPFS.
  • New risks address artificial intelligence adoption and uncertainties around future dividends and share repurchases under Texas law.

What changed since the prior 10-K

New

  • NewRISKS RELATED TO OUR BUSINESS AND OPERATIONS

    Our use of emerging technologies, including artificial intelligence, involves inherent risks

    The use of artificial intelligence and emerging technologies introduces operational, cybersecurity, compliance, and evolving regulatory risks.

  • NewRISKS RELATED TO OUR COMMON STOCK

    There can be no assurance that we will continue to increase our dividend or to repurchase shares of our common stock

    Future cash dividends and share repurchases are not guaranteed and may be restricted by Texas law, earnings, or capital requirements.

Reworded

  • 30% rewrittenRISKS RELATED TO OUR BUSINESS AND OPERATIONS

    The Medicare program reimburses outpatient rehabilitation providers based on the Medicare Physician Fee Schedule (“MPFS”). For services provided in 2026, we expect our reimbursement rates under the MPFS to increase by approximately 1.75% as compared to the applicable reimbursement rates during 2025

    Updated Medicare figures show 2025 net patient revenues of $213.5 million and an expected 1.75% reimbursement rate increase for 2026.

    Was: The Medicare program reimburses outpatient rehabilitation providers based on the Medicare Physician Fee Schedule (“MPFS”). For services provided in 2025, we expect our reimbursement rates under the MPFS to be approximately 2.9% less than the applicable reimbursement rates during 2024

  • 29% rewrittenRISKS RELATED TO OUR BUSINESS AND OPERATIONS

    We depend upon reimbursement by third-party payors

    Updated 2025 revenue mix to 64.2% from private payors and 35.8% from Medicare and Medicaid.

All 37 risk factors

Headings as the filing states them, in filing order.

RISKS RELATED TO OUR BUSINESS AND OPERATIONS

  1. 01Decreases in Medicare reimbursement rate may adversely affect our financial results
  2. 02The Medicare program reimburses outpatient rehabilitation providers based on the Medicare Physician Fee Schedule (“MPFS”). For services provided in 2026, we expect our reimbursement rates under the MPFS to increase by approximately 1.75% as compared to the applicable reimbursement rates during 202530% rewritten
  3. 03Revenue we receive from Medicare and Medicaid is subject to potential retroactive reduction
  4. 04We depend upon reimbursement by third-party payors29% rewritten
  5. 05Our facilities are subject to extensive federal and state laws and regulations relating to the privacy of individually identifiable patient information
  6. 06We are subject to risks associated with public health crises and epidemics/pandemics
  7. 07We expect the federal and state governments to continue their efforts to contain growth in Medicaid expenditures, which could adversely affect our revenue and profitability
  8. 08As a result of increased post-payment reviews of claims we submit to Medicare for our services, we may incur additional costs and may be required to repay amounts already paid to us
  9. 09An economic downturn, state budget pressures, sustained unemployment and continued deficit spending by the federal government may result in a reduction in reimbursement and covered services
  10. 10We may be required to comply with put rights in certain of our acquisition agreements, related to a potential future purchase of significant equity interests in our existing subsidiaries or a separate company
  11. 11Our debt and financial obligations could adversely affect our financial condition, our ability to obtain future financing, and our ability to operate our business
  12. 12impose on us financial and operational restrictions
  13. 13If we fail to satisfy our debt service obligations or the other restrictions and requirements in our loan agreements, we could be in default. Unless cured or waived, a default would permit lenders to accelerate the maturity of the debt under the credit agreement and to foreclose upon the collateral securing the debt
  14. 14In conducting our business, we are required to comply with applicable laws regarding fee-splitting and the corporate practice of medicine
  15. 15Some of our acquisition agreements contain contingent consideration, the value of which may impact future financial results
  16. 16Our contractual arrangements may not be as effective in providing control over our variable interest entities as direct ownership
  17. 17Impact on the business and cash reserves resulting from retirement or resignation of key partners and resulting purchase of their non-controlling interests (minority interests)
  18. 18Healthcare reform legislation may affect our business
  19. 19Our operations are subject to extensive regulation
  20. 20coding, billing and payment for services
  21. 21Our operations are subject to investigations, legal actions and proceedings that could result in an adverse impact on our business and financial position
  22. 22We face inspections, reviews, audits and investigations under federal and state government programs and contracts. These audits could have adverse findings that may negatively affect our business
  23. 23We may be adversely affected by a security breach, such as a cyber-attack, which may cause a violation of HIPAA or HITECH and subject us to potential legal and reputational harm
  24. 24We depend upon the cultivation and maintenance of relationships with the physicians in our markets
  25. 25Our business depends upon hiring, training, and retaining qualified employees
  26. 26We depend upon our ability to recruit and retain experienced physical therapists
  27. 27Failure to maintain effective internal control over our financial reporting could have an adverse effect on our ability to report our financial results on a timely and accurate basis
  28. 28Our revenues may fluctuate due to weather
  29. 29We operate in a highly competitive industry
  30. 30We may incur closure costs and losses
  31. 31Future acquisitions may use significant resources, may be unsuccessful and could expose us to unforeseen liabilities
  32. 32Employer and other contracted customers may terminate their relationship with us which could adversely affect the business
  33. 33Our use of emerging technologies, including artificial intelligence, involves inherent risksNew

RISKS RELATED TO OUR COMMON STOCK

  1. 34Issuance of shares in connection with financing transactions or under stock incentive plans will dilute current stockholders
  2. 35The number of shares of our common stock eligible for future sale could adversely affect the market price of our stock
  3. 36Provisions in our articles of incorporation and bylaws could delay or prevent a change in control of our company, even if that change would be beneficial to our stockholders
  4. 37There can be no assurance that we will continue to increase our dividend or to repurchase shares of our common stockNew

Other U S Physical Therapy 10-Ks

  • FY2024 10-K risk factors
    35 risks

    U.S. Physical Therapy relies heavily on Medicare reimbursement and private third-party payors for revenue generation. Complex healthcare regulations, compliance audits, and corporate practice restrictions govern daily clinic operations. Recruiting and retaining qualified physical therapists and maintaining physician referral relationships drive business success.

    Filed Mar 03, 2025

About this page

The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.